Similar Articles
501 Neoadjuvant treatment strategies for hepatocellular carcinoma
502 Liver resection vs radiofrequency ablation in single hepatocellular carcinoma of posterosuperior segments in elderly patients
503 Deep learning in hepatocellular carcinoma: Current status and future perspectives
504 New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study
505 Surgery for hepatocellular carcinoma with tumor thrombosis in inferior vena cava: A case report
506 Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
507 Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
508 Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
509 Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
510 Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA